CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
Accession: CHEBI:194135
browse the term
Definition: An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
Synonyms: related_synonym: Formula=C18H20FN3O4; InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25); InChIKey=GSDSWSVVBLHKDQ-UHFFFAOYSA-N; SMILES=CC1COC2=C(N3CCN(C)CC3)C(F)=CC3=C2N1C=C(C(O)=O)C3=O
G
Abhd1
abhydrolase domain containing 1
decreases expression
EXP
Levofloxacin results in decreased expression of ABHD1 mRNA
CTD
PMID:24136188
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
G
Acsf2
acyl-CoA synthetase family member 2
decreases expression
EXP
Levofloxacin results in decreased expression of ACSF2 mRNA
CTD
PMID:24136188
NCBI chr10:79,504,510...79,546,714
Ensembl chr10:79,504,511...79,546,673
G
Acsl5
acyl-CoA synthetase long-chain family member 5
decreases expression
EXP
Levofloxacin results in decreased expression of ACSL5 mRNA
CTD
PMID:24136188
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
G
Actg1
actin, gamma 1
decreases expression
EXP
Levofloxacin results in decreased expression of ACTG1 mRNA
CTD
PMID:24136188
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Acy1
aminoacylase 1
decreases expression
EXP
Levofloxacin results in decreased expression of ACY1 mRNA
CTD
PMID:24136188
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
G
Afp
alpha-fetoprotein
decreases expression
EXP
Levofloxacin results in decreased expression of AFP mRNA
CTD
PMID:24136188
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
decreases expression
EXP
Levofloxacin results in decreased expression of ALDH1B1 mRNA
CTD
PMID:24136188
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
G
Angptl6
angiopoietin-like 6
increases expression
EXP
Levofloxacin results in increased expression of ANGPTL6 mRNA
CTD
PMID:24136188
NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
G
Anxa1
annexin A1
decreases expression
EXP
Levofloxacin results in decreased expression of ANXA1 mRNA
CTD
PMID:24136188
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa2
annexin A2
decreases expression
EXP
Levofloxacin results in decreased expression of ANXA2 mRNA
CTD
PMID:24136188
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Ap1s1
adaptor related protein complex 1 subunit sigma 1
decreases expression
EXP
Levofloxacin results in decreased expression of AP1S1 mRNA
CTD
PMID:24136188
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
G
Arl4a
ADP-ribosylation factor like GTPase 4A
increases expression
EXP
Levofloxacin results in increased expression of ARL4A mRNA
CTD
PMID:24136188
NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066
G
Aspa
aspartoacylase
decreases expression
EXP
Levofloxacin results in decreased expression of ASPA mRNA
CTD
PMID:24136188
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
G
Atg2b
autophagy related 2B
increases expression
EXP
Levofloxacin results in increased expression of ATG2B mRNA
CTD
PMID:24136188
NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015
G
Atp6v0e2
ATPase, H+ transporting V0 subunit e2
decreases expression
EXP
Levofloxacin results in decreased expression of ATP6V0E2 mRNA
CTD
PMID:24136188
NCBI chr 4:77,484,868...77,488,016
Ensembl chr 4:77,482,226...77,488,777
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions
ISO
[Levofloxacin co-treated with TNF protein] results in increased expression of BIRC2 mRNA
CTD
PMID:32035082
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Bmp6
bone morphogenetic protein 6
decreases expression
ISO
Levofloxacin results in decreased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
EXP
Levofloxacin results in decreased expression of BST2 mRNA
CTD
PMID:24136188
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
Btg1
BTG anti-proliferation factor 1
increases expression
EXP
Levofloxacin results in increased expression of BTG1 mRNA
CTD
PMID:24136188
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
G
C2cd2
C2 calcium-dependent domain containing 2
decreases expression
EXP
Levofloxacin results in decreased expression of C2CD2 mRNA
CTD
PMID:24136188
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
G
C4b
complement C4B
increases expression
EXP
Levofloxacin results in increased expression of C4B mRNA
CTD
PMID:24136188
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
G
C5
complement C5
increases expression
EXP
Levofloxacin results in increased expression of C5 mRNA
CTD
PMID:24136188
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
C5l1
complement C5 like 1
increases expression
EXP
Levofloxacin results in increased expression of C5L1 mRNA
CTD
PMID:24136188
NCBI chr 3:18,401,716...18,420,064
Ensembl chr 3:18,404,899...18,420,054
G
C8h11orf54
similar to human chromosome 11 open reading frame 54
decreases expression
EXP
Levofloxacin results in decreased expression of C8H11ORF54 mRNA
CTD
PMID:24136188
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
G
C8h11orf65
similar to human chromosome 11 open reading frame 65
increases expression
EXP
Levofloxacin results in increased expression of C8H11ORF65 mRNA
CTD
PMID:24136188
NCBI chr 8:53,796,033...53,825,277
Ensembl chr 8:53,796,366...53,824,748
G
Car14
carbonic anhydrase 14
decreases expression
EXP
Levofloxacin results in decreased expression of CAR14 mRNA
CTD
PMID:24136188
NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693
G
Casp3
caspase 3
multiple interactions
ISO
[Levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein
CTD
PMID:30876886
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccdc6
coiled-coil domain containing 6
increases expression
EXP
Levofloxacin results in increased expression of CCDC6 mRNA
CTD
PMID:24136188
NCBI chr20:18,432,177...18,528,186
Ensembl chr20:18,433,695...18,528,658
G
Ccdc80
coiled-coil domain containing 80
decreases expression
EXP
Levofloxacin results in decreased expression of CCDC80 mRNA
CTD
PMID:24136188
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
G
Cd302
CD302 molecule
increases expression
EXP
Levofloxacin results in increased expression of CD302 mRNA
CTD
PMID:24136188
NCBI chr 3:44,722,324...44,756,045
Ensembl chr 3:44,722,325...44,756,045
G
Cdc42ep4
CDC42 effector protein 4
increases expression
EXP
Levofloxacin results in increased expression of CDC42EP4 mRNA
CTD
PMID:24136188
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
G
Cdk1
cyclin-dependent kinase 1
decreases expression
EXP
Levofloxacin results in decreased expression of CDK1 mRNA
CTD
PMID:24136188
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
EXP
Levofloxacin results in decreased expression of CDKN3 mRNA
CTD
PMID:24136188
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
EXP
Levofloxacin results in increased expression of CEBPB mRNA
CTD
PMID:24136188
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cfhr1
complement factor H-related 1
increases expression
EXP
Levofloxacin results in increased expression of CFHR1 mRNA
CTD
PMID:24136188
NCBI chr13:51,395,583...51,410,571
Ensembl chr13:51,369,211...51,410,592
G
Cgn
cingulin
decreases expression
EXP
Levofloxacin results in decreased expression of CGN mRNA
CTD
PMID:24136188
NCBI chr 2:182,308,389...182,335,747
Ensembl chr 2:182,308,714...182,334,645
G
Chpt1
choline phosphotransferase 1
increases expression
EXP
Levofloxacin results in increased expression of CHPT1 mRNA
CTD
PMID:24136188
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
EXP
Levofloxacin results in decreased expression of CKS2 mRNA
CTD
PMID:24136188
NCBI chr17:13,570,611...13,575,770
G
Clec14a
C-type lectin domain containing 14A
increases expression
EXP
Levofloxacin results in increased expression of CLEC14A mRNA
CTD
PMID:24136188
NCBI chr 6:75,881,470...75,884,612
Ensembl chr 6:75,881,473...75,884,612
G
Cmbl
carboxymethylenebutenolidase homolog
decreases expression
EXP
Levofloxacin results in decreased expression of CMBL mRNA
CTD
PMID:24136188
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression
EXP
Levofloxacin results in increased expression of CPT1A mRNA
CTD
PMID:24136188
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
increases expression
EXP
Levofloxacin results in increased expression of CYP27A1 mRNA
CTD
PMID:24136188
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
increases expression
EXP
Levofloxacin results in increased expression of CYP4B1 mRNA
CTD
PMID:24136188
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
G
Cyp51
cytochrome P450, family 51
increases expression
EXP
Levofloxacin results in increased expression of CYP51 mRNA
CTD
PMID:24136188
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
G
Ddc
dopa decarboxylase
decreases expression
EXP
Levofloxacin results in decreased expression of DDC mRNA
CTD
PMID:24136188
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddhd1
DDHD domain containing 1
decreases expression
EXP
Levofloxacin results in decreased expression of DDHD1 mRNA
CTD
PMID:24136188
NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Levofloxacin results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Dnajc9
DnaJ heat shock protein family (Hsp40) member C9
decreases expression
EXP
Levofloxacin results in decreased expression of DNAJC9 mRNA
CTD
PMID:24136188
NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
decreases expression
EXP
Levofloxacin results in decreased expression of DNPH1 mRNA
CTD
PMID:24136188
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
G
Dtymk
deoxythymidylate kinase
decreases expression
EXP
Levofloxacin results in decreased expression of DTYMK mRNA
CTD
PMID:24136188
NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870
G
Dut
deoxyuridine triphosphatase
decreases expression
EXP
Levofloxacin results in decreased expression of DUT mRNA
CTD
PMID:24136188
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
increases expression
EXP
Levofloxacin results in increased expression of EDEM1 mRNA
CTD
PMID:24136188
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
G
Elovl5
ELOVL fatty acid elongase 5
decreases expression
EXP
Levofloxacin results in decreased expression of ELOVL5 mRNA
CTD
PMID:24136188
NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284
G
Enc1
ectodermal-neural cortex 1
increases expression
EXP
Levofloxacin results in increased expression of ENC1 mRNA
CTD
PMID:24136188
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Ephx1
epoxide hydrolase 1
decreases expression
EXP
Levofloxacin results in decreased expression of EPHX1 mRNA
CTD
PMID:24136188
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Erg28
ergosterol biosynthesis 28 homolog
increases expression
EXP
Levofloxacin results in increased expression of ERG28 mRNA
CTD
PMID:24136188
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
G
Ergic1
endoplasmic reticulum-golgi intermediate compartment 1
decreases expression
EXP
Levofloxacin results in decreased expression of ERGIC1 mRNA
CTD
PMID:24136188
NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957
G
Fgl1
fibrinogen-like 1
increases expression
EXP
Levofloxacin results in increased expression of FGL1 mRNA
CTD
PMID:24136188
NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093
G
Fkbp4
FKBP prolyl isomerase 4
decreases expression
EXP
Levofloxacin results in decreased expression of FKBP4 mRNA
CTD
PMID:24136188
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
G
Fkbp5
FKBP prolyl isomerase 5
increases expression
EXP
Levofloxacin results in increased expression of FKBP5 mRNA
CTD
PMID:24136188
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
G
Flna
filamin A
decreases expression
EXP
Levofloxacin results in decreased expression of FLNA mRNA
CTD
PMID:24136188
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
G
Fndc3b
fibronectin type III domain containing 3B
increases expression
EXP
Levofloxacin results in increased expression of FNDC3B mRNA
CTD
PMID:24136188
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
G
Fzd8
frizzled class receptor 8
increases expression
EXP
Levofloxacin results in increased expression of FZD8 mRNA
CTD
PMID:24136188
NCBI chr17:57,312,924...57,320,551
Ensembl chr17:57,314,450...57,320,650
G
Gas6
growth arrest specific 6
increases expression
EXP
Levofloxacin results in increased expression of GAS6 mRNA
CTD
PMID:24136188
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression
EXP
Levofloxacin results in decreased expression of GCLC mRNA
CTD
PMID:24136188
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
decreases expression
EXP
Levofloxacin results in decreased expression of GPD1 mRNA
CTD
PMID:24136188
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
G
Hacd3
3-hydroxyacyl-CoA dehydratase 3
decreases expression
EXP
Levofloxacin results in decreased expression of HACD3 mRNA
CTD
PMID:24136188
NCBI chr 8:65,501,240...65,538,507
Ensembl chr 8:65,501,240...65,538,507
G
Haus4
HAUS augmin-like complex, subunit 4
decreases expression
EXP
Levofloxacin results in decreased expression of HAUS4 mRNA
CTD
PMID:24136188
NCBI chr15:27,994,530...28,006,147
Ensembl chr15:27,994,532...28,005,938
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
EXP
Levofloxacin results in increased expression of HERPUD1 mRNA
CTD
PMID:24136188
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hmgb2
high mobility group box 2
decreases expression
EXP
Levofloxacin results in decreased expression of HMGB2 mRNA
CTD
PMID:24136188
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
G
Hmgn2
high mobility group nucleosomal binding domain 2
decreases expression
EXP
Levofloxacin results in decreased expression of HMGN2 mRNA
CTD
PMID:24136188
NCBI chr 5:146,192,126...146,195,580
Ensembl chr 5:146,192,126...146,195,521 Ensembl chr16:146,192,126...146,195,521
G
Htatip2
HIV-1 Tat interactive protein 2
decreases expression
EXP
Levofloxacin results in decreased expression of HTATIP2 mRNA
CTD
PMID:24136188
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Icam1
intercellular adhesion molecule 1
decreases expression multiple interactions
ISO
Levofloxacin results in decreased expression of ICAM1 mRNA [Levofloxacin co-treated with TNF protein] results in increased expression of ICAM1 protein
CTD
PMID:32035082
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
Levofloxacin results in increased expression of IDI1 mRNA
CTD
PMID:24136188
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ifng
interferon gamma
increases expression
EXP
Levofloxacin results in increased expression of IFNG
CTD
PMID:24136188
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il1a
interleukin 1 alpha
increases expression
ISO
Levofloxacin results in increased expression of IL1A mRNA
CTD
PMID:32816093
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein
CTD
PMID:30876886
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il24
interleukin 24
increases expression
ISO
Levofloxacin results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Il6
interleukin 6
multiple interactions
ISO
[Levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein
CTD
PMID:30876886
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
increases expression
EXP
Levofloxacin results in increased expression of IL6R mRNA
CTD
PMID:24136188
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Ip6k2
inositol hexakisphosphate kinase 2
increases expression
EXP
Levofloxacin results in increased expression of IP6K2 mRNA
CTD
PMID:24136188
NCBI chr 8:109,483,843...109,510,172
Ensembl chr 8:109,484,310...109,510,166
G
Ivns1abp
influenza virus NS1A binding protein
increases expression
EXP
Levofloxacin results in increased expression of IVNS1ABP mRNA
CTD
PMID:24136188
NCBI chr13:63,427,040...63,446,701
Ensembl chr13:63,427,041...63,446,701
G
Klf15
KLF transcription factor 15
increases expression
EXP
Levofloxacin results in increased expression of KLF15 mRNA
CTD
PMID:24136188
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
G
Klf9
KLF transcription factor 9
increases expression
EXP
Levofloxacin results in increased expression of KLF9 mRNA
CTD
PMID:24136188
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
G
Kpna2
karyopherin subunit alpha 2
decreases expression
EXP
Levofloxacin results in decreased expression of KPNA2 mRNA
CTD
PMID:24136188
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Kpnb1
karyopherin subunit beta 1
decreases expression
EXP
Levofloxacin results in decreased expression of KPNB1 mRNA
CTD
PMID:24136188
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
G
Krt18
keratin 18
decreases expression
EXP
Levofloxacin results in decreased expression of KRT18 mRNA
CTD
PMID:24136188
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Lbp
lipopolysaccharide binding protein
increases expression
EXP
Levofloxacin results in increased expression of LBP mRNA
CTD
PMID:24136188
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lcmt1
leucine carboxyl methyltransferase 1
decreases expression
EXP
Levofloxacin results in decreased expression of LCMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:177,904,119...177,960,111
Ensembl chr 1:177,904,139...177,960,112
G
Lmnb1
lamin B1
decreases expression
EXP
Levofloxacin results in decreased expression of LMNB1 mRNA
CTD
PMID:24136188
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lmo7
LIM domain 7
decreases expression
EXP
Levofloxacin results in decreased expression of LMO7 mRNA
CTD
PMID:24136188
NCBI chr15:78,566,999...78,769,833
Ensembl chr15:78,567,023...78,769,783
G
Lpin1
lipin 1
increases expression
EXP
Levofloxacin results in increased expression of LPIN1 mRNA
CTD
PMID:24136188
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lurap1l
leucine rich adaptor protein 1-like
increases expression
EXP
Levofloxacin results in increased expression of LURAP1L mRNA
CTD
PMID:24136188
NCBI chr 5:95,362,005...95,409,439
Ensembl chr 5:95,362,005...95,409,438
G
Manba
mannosidase beta
decreases expression
EXP
Levofloxacin results in decreased expression of MANBA mRNA
CTD
PMID:24136188
NCBI chr 2:223,910,432...224,002,988
Ensembl chr 2:223,910,432...224,002,983
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions increases expression
ISO
[TNF protein co-treated with Levofloxacin] results in increased lipidation of MAP1LC3B protein; TNF protein promotes the reaction [Levofloxacin results in increased expression of MAP1LC3B protein]
CTD
PMID:33609687
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
EXP
Levofloxacin results in increased expression of MFSD2A mRNA
CTD
PMID:24136188
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
EXP
Levofloxacin results in increased expression of NAMPT mRNA
CTD
PMID:24136188
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
decreases expression
EXP
Levofloxacin results in decreased expression of NEDD9 mRNA
CTD
PMID:24136188
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
EXP
Levofloxacin results in decreased expression of NFE2L2 mRNA
CTD
PMID:24136188
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
increases expression multiple interactions
EXP ISO
Levofloxacin results in increased expression of NFKBIA mRNA [Levofloxacin co-treated with TNF protein] results in increased expression of NFKBIA mRNA
CTD
PMID:24136188 PMID:32035082
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbiz
NFKB inhibitor zeta
increases expression
EXP
Levofloxacin results in increased expression of NFKBIZ mRNA
CTD
PMID:24136188
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nrbp2
nuclear receptor binding protein 2
increases expression
EXP
Levofloxacin results in increased expression of NRBP2 mRNA
CTD
PMID:24136188
NCBI chr 7:107,798,642...107,805,225
Ensembl chr 7:107,799,497...107,805,230
G
Nudt4
nudix hydrolase 4
increases expression
EXP
Levofloxacin results in increased expression of NUDT4 mRNA
CTD
PMID:24136188
NCBI chr 7:30,188,100...30,204,615
Ensembl chr 7:30,188,100...30,204,615
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
EXP
Levofloxacin results in increased expression of NUPR1 mRNA
CTD
PMID:24136188
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Omd
osteomodulin
increases expression
EXP
Levofloxacin results in increased expression of OMD mRNA
CTD
PMID:24136188
NCBI chr17:15,060,217...15,068,441
Ensembl chr17:15,060,217...15,068,441
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression
EXP
Levofloxacin results in decreased expression of OSBPL1A mRNA
CTD
PMID:24136188
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
G
Palmd
palmdelphin
decreases expression
EXP
Levofloxacin results in decreased expression of PALMD mRNA
CTD
PMID:24136188
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
increases expression
EXP
Levofloxacin results in increased expression of PBLD1 mRNA
CTD
PMID:24136188
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression decreases expression
EXP ISO
Levofloxacin results in increased expression of PID1 mRNA Levofloxacin results in decreased expression of PID1 mRNA
CTD
PMID:24136188 PMID:32816093
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Pigu
phosphatidylinositol glycan anchor biosynthesis, class U
increases expression
EXP
Levofloxacin results in increased expression of PIGU mRNA
CTD
PMID:24136188
NCBI chr 3:143,784,831...143,881,268
Ensembl chr 3:143,784,832...143,880,807
G
Pla2g12a
phospholipase A2, group XIIA
increases expression
EXP
Levofloxacin results in increased expression of PLA2G12A mRNA
CTD
PMID:24136188
NCBI chr 2:218,436,497...218,452,742
Ensembl chr 2:218,436,513...218,452,740
G
Plgrkt
plasminogen receptor with a C-terminal lysine
decreases expression
EXP
Levofloxacin results in decreased expression of PLGRKT mRNA
CTD
PMID:24136188
NCBI chr 1:227,099,005...227,111,277
Ensembl chr 1:227,099,015...227,111,194
G
Plin3
perilipin 3
decreases expression
EXP
Levofloxacin results in decreased expression of PLIN3 mRNA
CTD
PMID:24136188
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
G
Plp2
proteolipid protein 2
decreases expression
EXP
Levofloxacin results in decreased expression of PLP2 mRNA
CTD
PMID:24136188
NCBI chr X:14,834,249...14,837,648
Ensembl chr X:14,834,231...14,838,514
G
Polg2
DNA polymerase gamma 2, accessory subunit
increases expression
EXP
Levofloxacin results in increased expression of POLG2 mRNA
CTD
PMID:24136188
NCBI chr10:91,712,586...91,723,008
Ensembl chr10:91,712,586...91,723,008
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
Levofloxacin results in decreased expression of PPARA mRNA
CTD
PMID:25689681
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppcs
phosphopantothenoylcysteine synthetase
increases expression
EXP
Levofloxacin results in increased expression of PPCS mRNA
CTD
PMID:24136188
NCBI chr 5:133,023,077...133,026,899
Ensembl chr 5:133,023,121...133,026,933
G
Ppif
peptidylprolyl isomerase F
decreases expression
EXP
Levofloxacin results in decreased expression of PPIF mRNA
CTD
PMID:24136188
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
G
Ppp1r14a
protein phosphatase 1, regulatory (inhibitor) subunit 14A
decreases expression
EXP
Levofloxacin results in decreased expression of PPP1R14A mRNA
CTD
PMID:24136188
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
G
Prkag2
protein kinase AMP-activated non-catalytic subunit gamma 2
decreases expression
EXP
Levofloxacin results in decreased expression of PRKAG2 mRNA
CTD
PMID:24136188
NCBI chr 4:10,010,890...10,252,155
Ensembl chr 4:10,010,890...10,252,142
G
Proser2
proline and serine rich 2
increases expression
EXP
Levofloxacin results in increased expression of PROSER2 mRNA
CTD
PMID:24136188
NCBI chr17:72,151,961...72,187,524
Ensembl chr17:72,151,872...72,185,825
G
Prxl2b
peroxiredoxin like 2B
increases expression
EXP
Levofloxacin results in increased expression of PRXL2B mRNA
CTD
PMID:24136188
NCBI chr 5:165,462,610...165,465,213
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Levofloxacin results in decreased expression of PTGS2 mRNA
CTD
PMID:32816093
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression
EXP
Levofloxacin results in decreased expression of PTTG1 mRNA
CTD
PMID:24136188
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Rapgef4
Rap guanine nucleotide exchange factor 4
increases expression
EXP
Levofloxacin results in increased expression of RAPGEF4 mRNA
CTD
PMID:24136188
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Levofloxacin co-treated with Lipopolysaccharides] affects the localization of RELA protein
CTD
PMID:32035082
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Retreg1
reticulophagy regulator 1
increases expression
EXP
Levofloxacin results in increased expression of RETREG1 mRNA
CTD
PMID:24136188
NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
G
Rmdn2
regulator of microtubule dynamics 2
decreases expression
EXP
Levofloxacin results in decreased expression of RMDN2 mRNA
CTD
PMID:24136188
NCBI chr 6:15,372,569...15,443,000
Ensembl chr 6:15,375,496...15,441,480
G
Rnd2
Rho family GTPase 2
increases expression
EXP
Levofloxacin results in increased expression of RND2 mRNA
CTD
PMID:24136188
NCBI chr10:86,399,151...86,402,750
Ensembl chr10:86,399,148...86,402,742
G
Rnf4
ring finger protein 4
decreases expression
EXP
Levofloxacin results in decreased expression of RNF4 mRNA
CTD
PMID:24136188
NCBI chr14:76,401,292...76,423,270
Ensembl chr14:76,401,299...76,422,566
G
Rnpepl1
arginyl aminopeptidase like 1
increases expression
EXP
Levofloxacin results in increased expression of RNPEPL1 mRNA
CTD
PMID:24136188
NCBI chr 9:93,476,600...93,486,331
Ensembl chr 9:93,472,390...93,486,331
G
Rpa1
replication protein A1
decreases expression
EXP
Levofloxacin results in decreased expression of RPA1 mRNA
CTD
PMID:24136188
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP
Levofloxacin results in decreased expression of RRM2 mRNA
CTD
PMID:24136188
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rsrp1
arginine and serine rich protein 1
decreases expression
EXP
Levofloxacin results in decreased expression of RSRP1 mRNA
CTD
PMID:24136188
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
Rxra
retinoid X receptor alpha
increases expression
EXP
Levofloxacin results in increased expression of RXRA mRNA
CTD
PMID:24136188
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Sc5d
sterol-C5-desaturase
increases expression
EXP
Levofloxacin results in increased expression of SC5D mRNA
CTD
PMID:24136188
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Sdc4
syndecan 4
increases expression
EXP
Levofloxacin results in increased expression of SDC4 mRNA
CTD
PMID:24136188
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
G
Serpina11
serpin family A member 11
increases expression
EXP
Levofloxacin results in increased expression of SERPINA11 mRNA
CTD
PMID:24136188
NCBI chr 6:122,903,246...122,912,695
Ensembl chr 6:122,903,250...122,912,670
G
Serpinh1
serpin family H member 1
decreases expression
EXP
Levofloxacin results in decreased expression of SERPINH1 mRNA
CTD
PMID:24136188
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
G
Sesn2
sestrin 2
increases expression
EXP
Levofloxacin results in increased expression of SESN2 mRNA
CTD
PMID:24136188
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sfpq
splicing factor proline and glutamine rich
decreases expression
EXP
Levofloxacin results in decreased expression of SFPQ mRNA
CTD
PMID:24136188
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sh3bp5
SH3-domain binding protein 5
increases expression
EXP
Levofloxacin results in increased expression of SH3BP5 mRNA
CTD
PMID:24136188
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,583,465...6,698,975
G
Slc13a3
solute carrier family 13 member 3
increases expression
EXP
Levofloxacin results in increased expression of SLC13A3 mRNA
CTD
PMID:24136188
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
G
Slc17a3
solute carrier family 17 member 3
decreases expression
EXP
Levofloxacin results in decreased expression of SLC17A3 mRNA
CTD
PMID:24136188
NCBI chr17:41,270,804...41,300,132
Ensembl chr17:41,270,812...41,295,256
G
Slc38a2
solute carrier family 38, member 2
increases expression
EXP
Levofloxacin results in increased expression of SLC38A2 mRNA
CTD
PMID:24136188
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Levofloxacin results in increased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slpi
secretory leukocyte peptidase inhibitor
decreases expression
ISO
Levofloxacin results in decreased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Spa17
sperm autoantigenic protein 17
decreases expression
EXP
Levofloxacin results in decreased expression of SPA17 mRNA
CTD
PMID:24136188
NCBI chr 8:37,307,432...37,318,519
Ensembl chr 8:37,307,557...37,318,639
G
Srxn1
sulfiredoxin 1
decreases expression
EXP
Levofloxacin results in decreased expression of SRXN1 mRNA
CTD
PMID:24136188
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
EXP
Levofloxacin results in decreased expression of SSX2IP mRNA
CTD
PMID:24136188
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
G
Stat3
signal transducer and activator of transcription 3
increases expression
EXP
Levofloxacin results in increased expression of STAT3 mRNA
CTD
PMID:24136188
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Steap3
STEAP3 metalloreductase
decreases expression
EXP
Levofloxacin results in decreased expression of STEAP3 mRNA
CTD
PMID:24136188
NCBI chr13:31,351,954...31,397,344
Ensembl chr13:31,351,954...31,396,519
G
Stmn1
stathmin 1
decreases expression
EXP
Levofloxacin results in decreased expression of STMN1 mRNA
CTD
PMID:24136188
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Synrg
synergin, gamma
increases expression
EXP
Levofloxacin results in increased expression of SYNRG mRNA
CTD
PMID:24136188
NCBI chr10:68,848,828...68,931,252
Ensembl chr10:68,849,642...68,931,250
G
Syvn1
synoviolin 1
increases expression
EXP
Levofloxacin results in increased expression of SYVN1 mRNA
CTD
PMID:24136188
NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
G
Tcirg1
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3
decreases expression
EXP
Levofloxacin results in decreased expression of TCIRG1 mRNA
CTD
PMID:24136188
NCBI chr 1:201,127,034...201,138,787
Ensembl chr 1:201,127,034...201,138,742
G
Tef
TEF transcription factor, PAR bZIP family member
increases expression
EXP
Levofloxacin results in increased expression of TEF mRNA
CTD
PMID:24136188
NCBI chr 7:113,317,191...113,341,783
Ensembl chr 7:113,317,283...113,341,783
G
Tjp2
tight junction protein 2
decreases expression
EXP
Levofloxacin results in decreased expression of TJP2 mRNA
CTD
PMID:24136188
NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295
G
Tkt
transketolase
decreases expression
EXP
Levofloxacin results in decreased expression of TKT mRNA
CTD
PMID:24136188
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
G
Tmem176b
transmembrane protein 176B
increases expression
EXP
Levofloxacin results in increased expression of TMEM176B mRNA
CTD
PMID:24136188
NCBI chr 4:77,766,928...77,774,740
Ensembl chr 4:77,766,928...77,774,384
G
Tmem38b
transmembrane protein 38B
increases expression
EXP
Levofloxacin results in increased expression of TMEM38B mRNA
CTD
PMID:24136188
NCBI chr 5:68,460,304...68,496,026
Ensembl chr 5:68,460,304...68,496,025
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Levofloxacin co-treated with TNF protein] results in increased expression of ICAM1 protein; [Levofloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA; [TNF protein co-treated with Levofloxacin] results in increased lipidation of MAP1LC3B protein; TNF protein promotes the reaction [Levofloxacin results in increased expression of MAP1LC3B protein] [Levofloxacin co-treated with TNF protein] results in increased expression of BIRC2 mRNA; [Levofloxacin co-treated with TNF protein] results in increased expression of ICAM1 protein; [Levofloxacin co-treated with TNF protein] results in increased expression of NFKBIA mRNA; [Levofloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA
CTD
PMID:30876886 PMID:32035082 PMID:33609687
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
multiple interactions
ISO
[Levofloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA
CTD
PMID:32035082
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip6
TNF alpha induced protein 6
decreases expression
ISO
Levofloxacin results in decreased expression of TNFAIP6 mRNA
CTD
PMID:32816093
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfrsf9
TNF receptor superfamily member 9
decreases expression
EXP
Levofloxacin results in decreased expression of TNFRSF9 mRNA
CTD
PMID:24136188
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tob2
transducer of ERBB2, 2
increases expression
EXP
Levofloxacin results in increased expression of TOB2 mRNA
CTD
PMID:24136188
NCBI chr 7:113,362,703...113,371,423
Ensembl chr 7:113,361,148...113,372,688
G
Tpm3
tropomyosin 3
decreases expression
EXP
Levofloxacin results in decreased expression of TPM3 mRNA
CTD
PMID:24136188
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
G
Tsc22d3
TSC22 domain family, member 3
increases expression
EXP
Levofloxacin results in increased expression of TSC22D3 mRNA
CTD
PMID:24136188
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Tstd3
thiosulfate sulfurtransferase like domain containing 3
decreases expression
EXP
Levofloxacin results in decreased expression of TSTD3 mRNA
CTD
PMID:24136188
NCBI chr 5:35,294,652...35,304,093
Ensembl chr 5:35,294,645...35,304,101
G
Tuba1c
tubulin, alpha 1C
decreases expression
EXP
Levofloxacin results in decreased expression of TUBA1C mRNA
CTD
PMID:24136188
NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tubb4b
tubulin, beta 4B class IVb
decreases expression
EXP
Levofloxacin results in decreased expression of TUBB4B mRNA
CTD
PMID:24136188
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
decreases expression
EXP
Levofloxacin results in decreased expression of TUBB5 mRNA
CTD
PMID:24136188
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tubb6
tubulin, beta 6 class V
decreases expression
EXP
Levofloxacin results in decreased expression of TUBB6 mRNA
CTD
PMID:24136188
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
G
Usp2
ubiquitin specific peptidase 2
increases expression
EXP
Levofloxacin results in increased expression of USP2 mRNA
CTD
PMID:24136188
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Levofloxacin results in increased expression of VCAM1 mRNA
CTD
PMID:24136188
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vim
vimentin
decreases expression
EXP
Levofloxacin results in decreased expression of VIM mRNA
CTD
PMID:24136188
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vmp1
vacuole membrane protein 1
increases expression
EXP
Levofloxacin results in increased expression of VMP1 mRNA
CTD
PMID:24136188
NCBI chr10:71,405,058...71,505,045
Ensembl chr10:71,405,452...71,505,007
G
Wasl
WASP like actin nucleation promoting factor
increases expression
EXP
Levofloxacin results in increased expression of WASL mRNA
CTD
PMID:24136188
NCBI chr 4:53,083,536...53,132,061
Ensembl chr 4:53,083,536...53,132,022
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
EXP
Levofloxacin results in increased expression of WIPI1 mRNA
CTD
PMID:24136188
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Xpo1
exportin 1
decreases expression
EXP
Levofloxacin results in decreased expression of XPO1 mRNA
CTD
PMID:24136188
NCBI chr14:97,233,282...97,275,536
Ensembl chr14:97,233,270...97,275,498
G
Zfp354a
zinc finger protein 354A
increases expression
EXP
Levofloxacin results in increased expression of ZFP354A mRNA
CTD
PMID:24136188
NCBI chr10:35,396,242...35,408,069
Ensembl chr10:35,396,231...35,408,068
G
Zfp446
zinc finger protein 446
increases expression
EXP
Levofloxacin results in increased expression of ZFP446 mRNA
CTD
PMID:24136188
NCBI chr 1:73,594,953...73,612,685
Ensembl chr 1:73,601,759...73,612,685
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity multiple interactions
ISO
Ofloxacin results in decreased activity of ABCB11 protein Ofloxacin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD
PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Arhgap45
Rho GTPase activating protein 45
affects expression
ISO
Ofloxacin affects the expression of ARHGAP45 mRNA
CTD
PMID:25811541
NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Ofloxacin results in increased expression of ASAH1 mRNA
CTD
PMID:17175557
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline]
CTD
PMID:11408986
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
[Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP3A4 protein results in increased metabolism of Theophylline]
CTD
PMID:11408986
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Ofloxacin results in increased expression of DEPP1 mRNA
CTD
PMID:17175557
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Ofloxacin inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]
CTD
PMID:16148020
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Ins1
insulin 1
increases expression
EXP
Ofloxacin results in increased expression of INS1 protein
CTD
PMID:17026994
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Itgb4
integrin subunit beta 4
decreases expression
ISO
Ofloxacin results in decreased expression of ITGB4 protein
CTD
PMID:14687228
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
affects binding
ISO
Ofloxacin binds to KCNH2 protein
CTD
PMID:34058295
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Mmp13
matrix metallopeptidase 13
multiple interactions decreases expression
ISO
Ofloxacin inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA] Ofloxacin results in decreased expression of MMP13 mRNA
CTD
PMID:16148020
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp3
matrix metallopeptidase 3
increases expression
EXP
Ofloxacin results in increased expression of MMP3 mRNA
CTD
PMID:20688128
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Ofloxacin results in increased expression of NUPR1 mRNA
CTD
PMID:17175557
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
Ofloxacin results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Phyh
phytanoyl-CoA 2-hydroxylase
decreases expression
ISO
Ofloxacin results in decreased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
G
Plaur
plasminogen activator, urokinase receptor
increases expression
EXP
Ofloxacin results in increased expression of PLAUR mRNA
CTD
PMID:20688128
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Ofloxacin results in increased expression of PTGS2 mRNA
CTD
PMID:20688128
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
RT1-A2
RT1 class Ia, locus A2
affects expression
ISO
Ofloxacin affects the expression of HLA-E mRNA
CTD
PMID:25811541
NCBI chr20:4,870,939...4,910,183
G
Slc22a5
solute carrier family 22 member 5
multiple interactions
ISO EXP
Ofloxacin inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]
CTD
PMID:16928358
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc2a1
solute carrier family 2 member 1
affects localization decreases expression
ISO
Ofloxacin affects the localization of SLC2A1 mRNA Ofloxacin results in decreased expression of SLC2A1 mRNA
CTD
PMID:19022360
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
EXP
Ofloxacin results in increased expression of TNFRSF12A mRNA
CTD
PMID:20688128
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of Ofloxacin
CTD
PMID:15769885
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of Ofloxacin
CTD
PMID:15769885
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of Ofloxacin
CTD
PMID:15769885
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all